A citation-based method for searching scientific literature

Kemal Ugur Tufekci, Ralph Meuwissen, Sermin Genc, Kursad Genc. Adv Protein Chem Struct Biol 2012
Times Cited: 133







List of co-cited articles
693 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
10

Oxidative stress in Parkinson's disease.
Peter Jenner. Ann Neurol 2003
10


Neuroinflammation in Parkinson's disease and its potential as therapeutic target.
Qinqin Wang, Yingjun Liu, Jiawei Zhou. Transl Neurodegener 2015
429
9


Neuroinflammation in Parkinson's disease.
Etienne C Hirsch, Sheela Vyas, Stéphane Hunot. Parkinsonism Relat Disord 2012
404
8

The role of oxidative stress in Parkinson's disease.
Vera Dias, Eunsung Junn, M Maral Mouradian. J Parkinsons Dis 2013
883
8



Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.
Vanessa Brochard, Béhazine Combadière, Annick Prigent, Yasmina Laouar, Aline Perrin, Virginie Beray-Berthat, Olivia Bonduelle, Daniel Alvarez-Fischer, Jacques Callebert, Jean-Marie Launay,[...]. J Clin Invest 2009
716
7

Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration.
Liya Qin, Xuefei Wu, Michelle L Block, Yuxin Liu, George R Breese, Jau-Shyong Hong, Darin J Knapp, Fulton T Crews. Glia 2007
7

Oxidative stress and Parkinson's disease.
Javier Blesa, Ines Trigo-Damas, Anna Quiroga-Varela, Vernice R Jackson-Lewis. Front Neuroanat 2015
448
7

Parkinson's disease: mechanisms and models.
William Dauer, Serge Przedborski. Neuron 2003
6

Pharmacological treatment of Parkinson disease: a review.
Barbara S Connolly, Anthony E Lang. JAMA 2014
760
6

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.
Mike A Nalls, Nathan Pankratz, Christina M Lill, Chuong B Do, Dena G Hernandez, Mohamad Saad, Anita L DeStefano, Eleanna Kara, Jose Bras, Manu Sharma,[...]. Nat Genet 2014
6

Neurodegeneration and inflammation in Parkinson's disease.
Sudarshan Phani, John D Loike, Serge Przedborski. Parkinsonism Relat Disord 2012
165
6

Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains.
Kazuhiro Imamura, Nozomi Hishikawa, Makoto Sawada, Toshiharu Nagatsu, Mari Yoshida, Yoshio Hashizume. Acta Neuropathol 2003
463
6

Microglial activation and chronic neurodegeneration.
Melinda E Lull, Michelle L Block. Neurotherapeutics 2010
600
6


NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review.
Ruey-Horng Shih, Chen-Yu Wang, Chuen-Mao Yang. Front Mol Neurosci 2015
448
6

Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells.
Isabella Russo, Giulia Berti, Nicoletta Plotegher, Greta Bernardo, Roberta Filograna, Luigi Bubacco, Elisa Greggio. J Neuroinflammation 2015
76
7

Mechanisms underlying inflammation in neurodegeneration.
Christopher K Glass, Kaoru Saijo, Beate Winner, Maria Carolina Marchetto, Fred H Gage. Cell 2010
6

Parkinson disease.
Werner Poewe, Klaus Seppi, Caroline M Tanner, Glenda M Halliday, Patrik Brundin, Jens Volkmann, Anette-Eleonore Schrag, Anthony E Lang. Nat Rev Dis Primers 2017
6

Epidemiology and etiology of Parkinson's disease: a review of the evidence.
Karin Wirdefeldt, Hans-Olov Adami, Philip Cole, Dimitrios Trichopoulos, Jack Mandel. Eur J Epidemiol 2011
667
5

Systemic infections and inflammation affect chronic neurodegeneration.
V Hugh Perry, Colm Cunningham, Clive Holmes. Nat Rev Immunol 2007
707
5

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.
Honglei Chen, Shumin M Zhang, Miguel A Hernán, Michael A Schwarzschild, Walter C Willett, Graham A Colditz, Frank E Speizer, Alberto Ascherio. Arch Neurol 2003
403
5

Peripheral cytokines profile in Parkinson's disease.
M Reale, C Iarlori, A Thomas, D Gambi, B Perfetti, M Di Nicola, M Onofrj. Brain Behav Immun 2009
327
5


Serum inflammatory biomarkers in Parkinson's disease.
M Dufek, M Hamanová, J Lokaj, D Goldemund, I Rektorová, Z Michálková, K Sheardová, I Rektor. Parkinsonism Relat Disord 2009
67
7

Preconditioning of microglia by α-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation.
Cintia Roodveldt, Adahir Labrador-Garrido, Elena Gonzalez-Rey, Christian C Lachaud, Tim Guilliams, Rafael Fernandez-Montesinos, Alicia Benitez-Rondan, Gema Robledo, Abdelkrim Hmadcha, Mario Delgado,[...]. PLoS One 2013
68
7


A review of Parkinson's disease.
C A Davie. Br Med Bull 2008
392
5

Parkinson's disease and systemic inflammation.
Carina C Ferrari, Rodolfo Tarelli. Parkinsons Dis 2011
129
5

Targets for neuroprotection in Parkinson's disease.
Talene A Yacoubian, David G Standaert. Biochim Biophys Acta 2009
119
5


Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain.
M Mogi, A Togari, T Kondo, Y Mizuno, O Komure, S Kuno, H Ichinose, T Nagatsu. J Neural Transm (Vienna) 2000
186
5

Protocol for the MPTP mouse model of Parkinson's disease.
Vernice Jackson-Lewis, Serge Przedborski. Nat Protoc 2007
639
5

Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
P Anglade, S Vyas, F Javoy-Agid, M T Herrero, P P Michel, J Marquez, A Mouatt-Prigent, M Ruberg, E C Hirsch, Y Agid. Histol Histopathol 1997
821
5

Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies.
Natália Pessoa Rocha, Aline Silva de Miranda, Antônio Lúcio Teixeira. Biomed Res Int 2015
130
5

Parkinson's disease: clinical features and diagnosis.
J Jankovic. J Neurol Neurosurg Psychiatry 2008
5

LRRK2 and neuroinflammation: partners in crime in Parkinson's disease?
Isabella Russo, Luigi Bubacco, Elisa Greggio. J Neuroinflammation 2014
108
5

Neurotoxic reactive astrocytes are induced by activated microglia.
Shane A Liddelow, Kevin A Guttenplan, Laura E Clarke, Frederick C Bennett, Christopher J Bohlen, Lucas Schirmer, Mariko L Bennett, Alexandra E Münch, Won-Suk Chung, Todd C Peterson,[...]. Nature 2017
5

Stages in the development of Parkinson's disease-related pathology.
Heiko Braak, Estifanos Ghebremedhin, Udo Rüb, Hansjürgen Bratzke, Kelly Del Tredici. Cell Tissue Res 2004
5

Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
R Betarbet, T B Sherer, G MacKenzie, M Garcia-Osuna, A V Panov, J T Greenamyre. Nat Neurosci 2000
4

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease.
Taye H Hamza, Cyrus P Zabetian, Albert Tenesa, Alain Laederach, Jennifer Montimurro, Dora Yearout, Denise M Kay, Kimberly F Doheny, Justin Paschall, Elizabeth Pugh,[...]. Nat Genet 2010
540
4

Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C Hirsch, Stéphane Hunot. Lancet Neurol 2009
4


Role of cytokines in inflammatory process in Parkinson's disease.
M Sawada, K Imamura, T Nagatsu. J Neural Transm Suppl 2006
239
4

Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease.
S Hunot, B Brugg, D Ricard, P P Michel, M P Muriel, M Ruberg, B A Faucheux, Y Agid, E C Hirsch. Proc Natl Acad Sci U S A 1997
566
4

Circulating interleukin-15 and RANTES chemokine in Parkinson's disease.
M Rentzos, C Nikolaou, E Andreadou, G P Paraskevas, A Rombos, M Zoga, A Tsoutsou, F Boufidou, E Kapaki, D Vassilopoulos. Acta Neurol Scand 2007
81
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.